Treatment-Naïve
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))
Active, not recruiting
- Prostate Cancer
- Multiparametric magnetic resonance imaging (mpMRI)
-
Taoyuan, TaiwanLi-Jen Wang
Nov 9, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023
Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)
Not yet recruiting
- Merkel Cell Carcinoma
- Pembrolizumab, Etoposide, Cisplatin or Carboplatin
-
Milano, Italy
- +2 more
Oct 10, 2023
The First Affiliated Hospital of Nanchang University Trial in Nanchang, Jinan (Orelabrutinib+R-CHOP)
Recruiting
- The First Affiliated Hospital of Nanchang University
-
Nanchang, Jiangxi, China
- +1 more
Jul 3, 2023
Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept
Not yet recruiting
- Diabetic Macular Edema
- +2 more
- Vitrectomy combined with ILM peeling
- Conbercept intravitreal injection
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Feb 14, 2023
Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib, Polatuzumab Vedotin, Rituximab
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 10, 2023
NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +8 more
-
New Haven, ConnecticutYale University
Oct 26, 2022
Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)
Recruiting
- Diffuse Large B Cell Lymphoma
- Rituximab
- +4 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)
Recruiting
- Severe Aplastic Anemia
- Eltrombopag
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)
Recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
- Orelabrutinib + R-CHOP
- Placebo + R-CHOP
-
Shanghai, Shanghai, ChinaShanghai Ruijing Hospital
Nov 28, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib (Arm A)
- Acalabrutinib (Arm B)
-
Bethesda, MarylandResearch Site
Jan 3, 2023
Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)
Completed
- Helicobacter Pylori Infection
- Amoxicillin
- +2 more
-
New York, New YorkMount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023
Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)
Not yet recruiting
- Advanced Cancer
- Clear Cell Renal Cell Carcinoma
- 177Lu girentuximab
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 15, 2022
Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)
Not yet recruiting
- Mucopolysaccharidosis (MPS)
- Hunter Syndrome
- ELAPRASE
- +3 more
- (no location specified)
Aug 8, 2022
Lamivudine and Dotiravir Sodium Tablets in Treatment-naïve HIV-1
Not yet recruiting
- HIV-1-infection
- Lamivudine and Dotiravir Sodium Tablets
- (no location specified)
Apr 10, 2022
Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)
Recruiting
- Severe Aplastic Anemia
- Hetrombopag Olamine+Standard Therapy
- Placebo+Standard Therapy
-
Tianjin, Tianjin, ChinaBlood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022
Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)
Not yet recruiting
- Mantle Cell Lymphoma (MCL)
- Acalabrutinib
- +2 more
-
Duarte, California
- +11 more
Jul 17, 2023
Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)
Completed
- Chronic Hepatitis B
- NCO-48 Fumarate 4 mg
- +2 more
-
Monterey Park, CaliforniaNational Institute of Clinical Research, Inc
Jan 3, 2023